entity-batch: update 1 entities

- Applied 1 entity operations from queue
- Files: entities/internet-finance/kalshi.md

Pentagon-Agent: Epimetheus <968B2991-E2DF-4006-B962-F5B0A0CC8ACA>

domains/ai-alignment/AI alignment is a coordination problem not a technical problem.md

@@ -33,6 +33,12 @@ Ruiz-Serra et al. (2024) provide formal evidence for the coordination framing th
 
 The UK AI4CI research strategy treats alignment as a coordination and governance challenge requiring institutional infrastructure. The seven trust properties (human agency, security, privacy, transparency, fairness, value alignment, accountability) are framed as system architecture requirements, not as technical ML problems. The strategy emphasizes 'establishing and managing appropriate infrastructure in a way that is secure, well-governed and sustainable' and includes regulatory sandboxes, trans-national governance, and trustworthiness assessment as core components. The research agenda focuses on coordination mechanisms (federated learning, FAIR principles, multi-stakeholder governance) rather than on technical alignment methods like RLHF or interpretability.
 
+
+### Additional Evidence (confirm)
+*Source: [[2026-01-15-eu-ai-alliance-seven-feedback-loops]] | Added: 2026-03-18*
+
+The source identifies three market failure mechanisms driving over-adoption: (1) negative externalities where firms don't internalize demand destruction, (2) coordination failure where 'follow or die' dynamics force adoption despite systemic risks, (3) information asymmetry where adoption signals inevitability. All three are coordination failures, not technical capability gaps.
+
 ---
 
 Relevant Notes:

domains/entertainment/youtube-first-distribution-for-major-studio-coproductions-signals-platform-primacy-over-traditional-broadcast-windowing.md

@@ -41,6 +41,16 @@ The Claynosaurz-Mediawan co-production will launch on YouTube first, then sell t
 
 Pudgy Penguins chose to launch Lil Pudgys on its own YouTube channel (13K subscribers) rather than leveraging TheSoul Publishing's 2B+ follower distribution network. This extends the claim by showing that YouTube-first distribution can mean building a DEDICATED brand channel rather than parasitizing existing platform reach. The decision prioritizes brand ownership over reach maximization, suggesting YouTube-first is not just about platform primacy but about audience ownership architecture.
 
+
+### Auto-enrichment (near-duplicate conversion, similarity=1.00)
+*Source: PR #1238 — "youtube first distribution for major studio coproductions signals platform primacy over traditional broadcast windowing"*
+*Auto-converted by substantive fixer. Review: revert if this evidence doesn't belong here.*
+
+### Additional Evidence (confirm)
+*Source: [[2025-10-01-variety-claynosaurz-creator-led-transmedia]] | Added: 2026-03-18*
+
+Claynosaurz 39-episode animated series launching YouTube-first before selling to TV/streaming, co-produced with Method Animation (Mediawan). Nic Cabana frames this as 'already here' not speculative, with community's 1B social views creating guaranteed algorithmic traction that studios pay millions to achieve through marketing.
+
 ---
 
 Relevant Notes:

domains/health/GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035.md

@@ -83,18 +83,6 @@ Danish cohort achieved same weight loss outcomes (16.7% at 64 weeks) using HALF
 
 BALANCE Model's dual payment mechanism (capitation adjustment + reinsurance) plus manufacturer-funded lifestyle support represents the first major policy attempt to address the chronic-use cost structure. The Medicare GLP-1 Bridge (July 2026) provides immediate price relief while full model architecture is built, indicating urgency around cost containment.
 
-
-### Additional Evidence (challenge)
-*Source: [[2026-02-01-glp1-patent-cliff-generics-global-competition]] | Added: 2026-03-18*
-
-International generic competition beginning in 2026 will compress prices faster than the existing claim assumes. Canada's semaglutide patents expired January 4, 2026, with Sandoz, Apotex, and Teva filing immediately. Brazil opens to generics March 2026 (Biomm + Biocon). China has 17+ Phase 3 generic candidates targeting $40-$50/month pricing. India patents expire March 2026. Even before US generics (2031-2033), international price arbitrage and compounding pharmacy pressure will drive US prices below $100/month by 2030. At $50-100/month, GLP-1s become unambiguously cost-effective under any payment model, potentially shifting the inflection point (where volume growth no longer offsets price compression) significantly earlier than 2035.
-
-
-### Additional Evidence (extend)
-*Source: [[2026-02-01-glp1-patent-cliff-generics-global-competition]] | Added: 2026-03-18*
-
-Oral Wegovy launched January 2026 at $149-$299/month (vs $1,349/month for injectable), with Medicare deal at $245/month. This represents 82-89% price compression from injectable to oral formulation within the branded market, before any generic competition. The oral formulation shift accelerates the price decline trajectory independent of patent expiry.
-
 ---
 
 Relevant Notes:

entities/internet-finance/kalshi.md

@@ -50,6 +50,7 @@ CFTC-designated contract market for event-based trading. USD-denominated, KYC-re
 - **2025-08-01** — Maryland District Court ruled against Kalshi in KalshiEx v. Martin, finding dual compliance with state gambling laws theoretically possible and rejecting field preemption argument (Fourth Circuit appeal No. 25-1892 pending)
 - **2026-01-09** — Tennessee Middle District Court ruled in favor of Kalshi in KalshiEx v. Orgel, finding impossibility of dual compliance and obstacle to federal objectives, creating circuit split with Maryland
 - **2026-03-17** — Arizona AG filed 20 criminal counts including illegal gambling and election wagering — first-ever criminal charges against a US prediction market platform
+- **2026-01-09** — Tennessee court ruled in favor of Kalshi in KalshiEx v. Orgel, finding impossibility of dual compliance and obstacle to federal objectives, creating circuit split with Maryland
 ## Competitive Position
 - **Regulation-first**: Only CFTC-designated prediction market exchange. Institutional credibility.
 - **vs Polymarket**: Different market — Kalshi targets mainstream/institutional users who won't touch crypto. Polymarket targets crypto-native users who want permissionless market creation. Both grew massively post-2024 election.

inbox/archive/.extraction-debug/2026-01-15-eu-ai-alliance-seven-feedback-loops.json

@@ -0,0 +1,43 @@
+{
+  "rejected_claims": [
+    {
+      "filename": "competitive-ai-adoption-creates-demand-destruction-feedback-loop-through-follow-or-die-dynamics.md",
+      "issues": [
+        "missing_attribution_extractor"
+      ]
+    },
+    {
+      "filename": "exponential-technology-with-linear-governance-creates-meta-loop-accelerating-all-other-feedback-loops.md",
+      "issues": [
+        "missing_attribution_extractor"
+      ]
+    },
+    {
+      "filename": "ai-productivity-gains-translate-to-worker-earnings-at-only-3-to-7-percent-creating-structural-demand-gap.md",
+      "issues": [
+        "missing_attribution_extractor"
+      ]
+    }
+  ],
+  "validation_stats": {
+    "total": 3,
+    "kept": 0,
+    "fixed": 6,
+    "rejected": 3,
+    "fixes_applied": [
+      "competitive-ai-adoption-creates-demand-destruction-feedback-loop-through-follow-or-die-dynamics.md:set_created:2026-03-18",
+      "competitive-ai-adoption-creates-demand-destruction-feedback-loop-through-follow-or-die-dynamics.md:stripped_wiki_link:the alignment tax creates a structural race to the bottom",
+      "competitive-ai-adoption-creates-demand-destruction-feedback-loop-through-follow-or-die-dynamics.md:stripped_wiki_link:economic forces push humans out of every cognitive loop wher",
+      "exponential-technology-with-linear-governance-creates-meta-loop-accelerating-all-other-feedback-loops.md:set_created:2026-03-18",
+      "ai-productivity-gains-translate-to-worker-earnings-at-only-3-to-7-percent-creating-structural-demand-gap.md:set_created:2026-03-18",
+      "ai-productivity-gains-translate-to-worker-earnings-at-only-3-to-7-percent-creating-structural-demand-gap.md:stripped_wiki_link:economic forces push humans out of every cognitive loop wher"
+    ],
+    "rejections": [
+      "competitive-ai-adoption-creates-demand-destruction-feedback-loop-through-follow-or-die-dynamics.md:missing_attribution_extractor",
+      "exponential-technology-with-linear-governance-creates-meta-loop-accelerating-all-other-feedback-loops.md:missing_attribution_extractor",
+      "ai-productivity-gains-translate-to-worker-earnings-at-only-3-to-7-percent-creating-structural-demand-gap.md:missing_attribution_extractor"
+    ]
+  },
+  "model": "anthropic/claude-sonnet-4.5",
+  "date": "2026-03-18"
+}

inbox/archive/2026-01-15-eu-ai-alliance-seven-feedback-loops.md

@@ -7,12 +7,16 @@ date: 2026-01-15
 domain: ai-alignment
 secondary_domains: [internet-finance, grand-strategy]
 format: essay
-status: unprocessed
+status: enrichment
 priority: high
 triage_tag: claim
 tags: [feedback-loops, economic-disruption, demand-destruction, automation-overshoot, coordination-failure, market-failure, systemic-risk]
 flagged_for_rio: ["Seven self-reinforcing economic feedback loops from AI automation — connects to market failure analysis and coordination mechanisms"]
 flagged_for_leo: ["Systemic coordination failure framework — individual firm optimization creating collective demand destruction"]
+processed_by: theseus
+processed_date: 2026-03-18
+enrichments_applied: ["AI alignment is a coordination problem not a technical problem.md"]
+extraction_model: "anthropic/claude-sonnet-4.5"
 ---
 
 ## Content
@@ -55,3 +59,12 @@ Seven self-reinforcing feedback loops identified in AI's economic impact:
 ## Curator Notes
 PRIMARY CONNECTION: the alignment tax creates a structural race to the bottom because safety training costs capability and rational competitors skip it
 WHY ARCHIVED: Provides seven specific feedback loops explaining HOW the race-to-the-bottom dynamic operates economically. L1 is the alignment tax applied to automation decisions. L7 is our temporal mismatch claim applied to governance response.
+
+
+## Key Facts
+- 78% of organizations now use AI as of 2026
+- 40% of employers plan workforce reductions due to AI
+- 92% of C-suite executives report up to 20% workforce overcapacity
+- Only 3-7% of AI productivity improvements translate to higher worker earnings
+- 77% of new AI jobs require master's degrees
+- J-curve pattern shows initial 60-percentage-point productivity declines during 12-24 month AI adjustment periods

inbox/archive/2026-02-01-glp1-patent-cliff-generics-global-competition.md

@@ -7,13 +7,9 @@ date: 2026-02-01
 domain: health
 secondary_domains: [internet-finance]
 format: article
-status: enrichment
+status: unprocessed
 priority: medium
 tags: [glp-1, generics, patent-cliff, global-competition, drug-pricing, market-structure]
-processed_by: vida
-processed_date: 2026-03-18
-enrichments_applied: ["GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035.md", "GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035.md"]
-extraction_model: "anthropic/claude-sonnet-4.5"
 ---
 
 ## Content
@@ -54,16 +50,3 @@ Overview of the GLP-1 generic competition landscape as patents begin expiring in
 PRIMARY CONNECTION: [[GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035]]
 WHY ARCHIVED: Price trajectory is the key variable the existing claim depends on — if prices decline faster than assumed, the "inflationary through 2035" conclusion may be wrong
 EXTRACTION HINT: Focus on the price trajectory and its implications for cost-effectiveness under different payment models, especially the international competition pressure
-
-
-## Key Facts
-- Semaglutide patents extend to 2031-2032 in US and Europe
-- Canada became first G7 nation with semaglutide patent expiry on January 4, 2026
-- Sandoz, Apotex, and Teva filed for Canadian generic semaglutide immediately after patent expiry
-- Brazil generic competition opens March 2026 with Biomm + Biocon (India) preparing generic semaglutide
-- China has 17+ generic semaglutide candidates in Phase 3 trials
-- India semaglutide patent expirations scheduled March 2026
-- Oral Wegovy launched January 2026 at $149-$299/month
-- Medicare negotiated oral Wegovy price: $245/month
-- Injectable Wegovy list price: $1,349/month
-- China/India projected generic semaglutide pricing: $40-$50/month